| Product NDC: | 51808-201 |
| Proprietary Name: | ACD Solution Modified |
| Non Proprietary Name: | ACD Solution Modified |
| Active Ingredient(s): | 8 mg/mL & nbsp; ACD Solution Modified |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 51808-201 |
| Labeler Name: | AnazaoHealth Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | |
| Marketing Category: | UNAPPROVED DRUG OTHER |
| Start Marketing Date: | 20120523 |
| Package NDC: | 51808-201-01 |
| Package Description: | 10 mL in 1 VIAL (51808-201-01) |
| NDC Code | 51808-201-01 |
| Proprietary Name | ACD Solution Modified |
| Package Description | 10 mL in 1 VIAL (51808-201-01) |
| Product NDC | 51808-201 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ACD Solution Modified |
| Dosage Form Name | SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20120523 |
| Marketing Category Name | UNAPPROVED DRUG OTHER |
| Labeler Name | AnazaoHealth Corporation |
| Substance Name | ANHYDROUS CITRIC ACID |
| Strength Number | 8 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] |